Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum

NCT02733094 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT02733094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02733094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum
Lead sponsor
Technical University of Munich
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2016
Completion date
September 19, 2019
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pyoderma gangrenosum